Isomorphic Labs raises $5B to advance AI-discovered drug candidates into clinical trials
Isomorphic Labs, an AI-driven drug discovery company that was spun out of Google's DeepMind in 2021, has closed a $5 billion Series C funding round. The company says the capital will help it move its drug candidates toward clinical trials. The round marks a major financing milestone for the firm as it shifts from research toward human testing. The source article provides limited further detail on the specific timeline or candidates involved.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in